Pharmafile Logo

norovirus

- PMLiVE

Innovative Trials named a finalist in the Inspiring Hertfordshire Awards

The patient recruitment organisation has been shortlisted in the Inspiring Hertfordshire awards

Innovative Trials

- PMLiVE

Rare cancer specialists Sierra Oncology acquired by GSK for £1.5bn

Unification will help to uphold and progress promising Momelotinib treatment which targets myelofibrosis

Importance of Diversity in Pharma and Clinical Trials

No matter which sector you work in, diversity and inclusion are must-haves!

Impetus Digital

- PMLiVE

GSK and CureVac sign deal with Germany for mRNA COVID-19 vaccines

The agreement is part of a Pandemic Preparedness Contract and means millions of vaccines can be produced at short notice during future public health emergencies

Democratizing Brain Health with Digital Assessments

Dr. Pam Ventola, Senior Science Director at Cogstate, shares how the company is working to optimize brain health assessments in rare disease and pediatric clinical trials, and how this can...

Impetus Digital

- PMLiVE

Innovative Trials suspends services in Russia in response to Ukraine war

Kate Shaw, Founder & CEO of the leading patient recruitment organisation based in Letchworth (UK), on the current Russia-Ukraine situation.

Innovative Trials

- PMLiVE

Improving diversity in clinical trial patient recruitment

A key requirement for clinical trials is to understand the effect of potential treatments on the patient populations that will benefit most. Despite this, many studies find diverse patient recruitment...

Innovative Trials

Increasing patient randomisation rate by 200% for a Top 5 global pharma

Phase IIa Moderate to Severe Hidradenitis Suppurativa Case Study

Innovative Trials

- PMLiVE

FDA issues final guidances for clinical cancer trials

The FDA is working to address inequities, target the right treatments to the right patients and speed progress against the most deadly and rare cancers

- PMLiVE

Eating Disorders Awareness Week

In the latest blog post, Innovative Trials' Equality & Diversity committee focuses on eating disorders

Innovative Trials

Takeda agrees on $2bn deal with Code Bio to expand its gene therapy programmes

The pharma company will gain opt-in rights for four rare diseases candidates

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links